Literature DB >> 24270181

Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension.

Michael A Weber1, Ernesto L Schiffrin, William B White, Samuel Mann, Lars H Lindholm, John G Kenerson, John M Flack, Barry L Carter, Barry J Materson, C Venkata S Ram, Debbie L Cohen, Jean-Claude Cadet, Roger R Jean-Charles, Sandra Taler, David Kountz, Raymond Townsend, John Chalmers, Agustin J Ramirez, George L Bakris, Jiguang Wang, Aletta E Schutte, John D Bisognano, Rhian M Touyz, Dominic Sica, Stephen B Harrap.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24270181     DOI: 10.1097/HJH.0000000000000065

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  200 in total

1.  Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells.

Authors:  Ken Chen; Kun Deng; Xiaoyan Wang; Zhen Wang; Shuo Zheng; Hongmei Ren; Duofen He; Yu Han; Laureano D Asico; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Hypertension Guidelines: Timely New Initiatives from East Asia.

Authors:  John Chalmers
Journal:  Pulse (Basel)       Date:  2015-04-29

Review 3.  Recognition and Management of Hypertension in Older Persons: Focus on African Americans.

Authors:  Carolyn H Still; Keith C Ferdinand; Gbenga Ogedegbe; Jackson T Wright
Journal:  J Am Geriatr Soc       Date:  2015-10       Impact factor: 5.562

Review 4.  Combination therapy of renin-angiotensin system inhibitors plus calcium channel blockers versus other two-drug combinations for hypertension: a systematic review and meta-analysis.

Authors:  Z Lu; Y Chen; L Li; G Wang; H Xue; W Tang
Journal:  J Hum Hypertens       Date:  2016-01-07       Impact factor: 3.012

5.  Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention.

Authors:  Daniel A Nation; Jean Ho; Belinda Yew
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

6.  Rate of change in renal function and mortality in elderly treated hypertensive patients.

Authors:  Enayet K Chowdhury; Robyn G Langham; Zanfina Ademi; Alice Owen; Henry Krum; Lindon M H Wing; Mark R Nelson; Christopher M Reid
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-21       Impact factor: 8.237

7.  Comparison of carotid plaque burden among healthy middle-aged men living in the US, Japan, and South Korea.

Authors:  Abhishek Vishnu; Jina Choo; Aya Kadota; Emma J M Barinas-Mitchell; Akira Fujiyoshi; Dorothy Leann Long; Takashi Hisamatsu; Vasudha Ahuja; Yasuyuki Nakamura; Rhobert W Evans; Katsuyuki Miura; Kamal H Masaki; Chol Shin; Hirotsugu Ueshima; Akira Sekikawa
Journal:  Int J Cardiol       Date:  2018-09-01       Impact factor: 4.164

Review 8.  A practical approach to the pharmacological management of hypertension in older people.

Authors:  Nikesh Parekh; Amy Page; Khalid Ali; Kevin Davies; Chakravarthi Rajkumar
Journal:  Ther Adv Drug Saf       Date:  2016-12-27

9.  Circulating miR-92a expression level in patients with essential hypertension: a potential marker of atherosclerosis.

Authors:  Y Huang; S Tang; C Ji-Yan; C Huang; J Li; A-P Cai; Y-Q Feng
Journal:  J Hum Hypertens       Date:  2016-09-15       Impact factor: 3.012

10.  Long-Term Mortality in Hypertensive Patients With Coronary Artery Disease: Results From the US Cohort of the International Verapamil (SR)/Trandolapril Study.

Authors:  Islam Y Elgendy; Anthony A Bavry; Yan Gong; Eileen M Handberg; Rhonda M Cooper-DeHoff; Carl J Pepine
Journal:  Hypertension       Date:  2016-09-12       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.